
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million
5/11/2026
0:00
2:27
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.
Altri episodi di "Pharmaceutical Executive"



Non perdere nemmeno un episodio di “Pharmaceutical Executive”. Iscriviti all'app gratuita GetPodcast.








